Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Adenocarcinoma of Head of Pancreas
Both
Adenocarcinoma of Head of Pancreas
Trial Information
Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
Inclusion Criteria:
- Patients with (or suspected) pancreatic head cancer
- Being examined by contrasted-enhanced MDCT
- Receiving surgical treatment (including palliative surgery) in all research centers
Exclusion Criteria:
- Patients having (or suspected) pregnancy or breast-feeding
- Patients having allergic reactions to iodinated contrast agents or Hypersensitivity
reactions to allergens(including drugs)
- Patients receiving ERCP before contrasted-enhanced MDCT examination
- Patients without surgery because of a high degree of surgical risk
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Mengsu Zeng, MD, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
Radiology Department, Zhongshan Hospital of Fudan University
Authority:
United States: Institutional Review Board
Study ID:
ZMS-001
NCT ID:
NCT01455610
Start Date:
October 2011
Completion Date:
October 2012
Related Keywords:
- Adenocarcinoma of Head of Pancreas
- Computed tomography
- Contrast enhancement
- Pancreas
- Cancer
- Resectability
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Head and Neck Neoplasms
Name | Location |
|---|
